Rohto Pharmaceutical Co(JP:4527)
¥2,661.50+18.50 (+0.70%)
JP:4527
Rohto Pharmaceutical Co earnings date
¥2,661.50
At close:+18.50 (+0.70%)
Want to see JP:4527 full AI Analyst Report?
Rohto Pharmaceutical Co (4527) Q2 2025 Earnings Report
2 Followers
JP:4527 Q2 2025 EPS Results
- Actual EPS
- JPY 26.03
- Consensus EPS
- JPY 24.98
- Beat/Miss
- Beat by +JPY 1.05
- One Year Ago EPS
- JPY 19.46
JP:4527 Q2 2025 Revenue Results
- Actual Revenue
- JPY 82.29B
- Expected Revenue
- JPY 81.16B
- Beat/Miss
- Beat by +JPY 1.14B
- YoY Revenue Growth
- +16.35%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 11/13/2025
- Time
- TBA
- Conference Call
- Thursday, November 13, 2025
JP:4527 Upcoming Earnings
Rohto Pharmaceutical Co's next earnings date is estimated for February 12, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
JP:4527 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4527 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 12, 2027 | 2026 (Q3) | 52.30- | 47.03 | ― | ― |
| Nov 12, 2026 | 2026 (Q2) | 32.6525.94 | 26.03 | -0.35% (-0.09) | |
| Aug 06, 2026 | 2026 (Q1) | 39.8647.14 | 52.09 | -9.50% (-4.95) | |
| May 13, 2026 | 2025 (Q4) | 30.3626.41 | 27.38 | -3.54% (-0.97) | |
| Feb 12, 2026 | 2025 (Q3) | 44.1147.03 | 52.09 | -9.71% (-5.06) | |
| Nov 13, 2025 | 2025 (Q2) | 24.9826.03 | 19.46 | 33.76% (+6.57) | |
| Aug 06, 2025 | 2025 (Q1) | ―52.09 | 37.18 | 40.10% (+14.91) | |
| May 13, 2025 | 2024 (Q4) | 24.9627.38 | 20.95 | 30.69% (+6.43) | |
| Feb 12, 2025 | 2024 (Q3) | 49.0952.09 | 41.92 | 24.26% (+10.17) | |
| Nov 13, 2024 | 2024 (Q2) | 35.0719.46 | 32.89 | -40.83% (-13.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


